<?xml version="1.0" encoding="UTF-8"?>
<p>Product safety report on MELORA™ Mānuka oil (&lt;5%) according to EC Regulation 1223/2009 detailed high skin tolerance and good cosmetic acceptability of the product. The formulation has a relatively high content of β-triketones, such as flavesone, isoleptospermone, leptospermone and grandiflorone. Acute toxicities based on the routes of administration were LD
 <sub>50</sub> = 1061 mg/kg body weight and LD
 <sub>50</sub> &gt; 2000 mg/kg body weight for oral and dermal administration, respectively. No irritation was noted on testing the formulation on rabbit eye mucous membranes. There was no skin sensitization or genetic toxicity after a micronucleus test in TK6 Human lymphoblastoid cells and bacterial reverse mutation test in 
 <italic>Salmonella typhimurium</italic> and 
 <italic>E. coli</italic>. It is intended for external use, could cause irritations in the eye on direct contact and a patch test is suggested before use [
 <xref rid="B6-pharmaceuticals-13-00343" ref-type="bibr">6</xref>]. 
</p>
